PEN250117C210000
- 14.80
- 0.000.00%
Penumbra Newsroom
Capital Allocation Trends At Penumbra (NYSE:PEN) Aren't Ideal
Penumbra, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference
(PEN) - Analyzing Penumbra's Short Interest
Here's Why You Should Add HAE Stock to Your Portfolio Now
Insider Sale: CEO and President of $PEN (PEN) Sells 1,029 Shares
Penumbra(PEN.US) Officer Sells US$3.64 Million in Common Stock
Here's Why Penumbra (PEN) Is a Strong Growth Stock
RBC Capital Maintains Penumbra(PEN.US) With Buy Rating, Raises Target Price to $285
10 Health Care Stocks With Whale Alerts In Today's Session
Penumbra Is Maintained at Buy by Truist Securities
Truist Securities Adjusts Price Target on Penumbra to $285 From $240, Keeps Buy Rating
Truist Financial Maintains Penumbra(PEN.US) With Buy Rating, Raises Target Price to $285
Express News | Penumbra Inc : RBC Raises Target Price to $285 From $232
Penumbra Is Poised For Growth As Blood Clot Awareness Rises: Analyst
Oppenheimer Maintains Penumbra(PEN.US) With Buy Rating, Maintains Target Price $275
This Elastic Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Penumbra Initiated at Outperform by Oppenheimer
Oppenheimer Initiates Penumbra(PEN.US) With Buy Rating, Announces Target Price $275
3 Medical Instruments Industry Stocks to Buy on the GenAI Wave
Top Gap Ups and Downs on Wednesday: MLI, MSTR, GSK and More